“…A disease whose reputation is often worse than its reality, hepatitis C is usually benign. Most infected individuals do not experience symptoms requiring treatment, and roughly half of those treated will become free of detectable virus for an extended, perhaps permanent, period. …”
Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso
Enlace del recurso

“…We will discuss in this paper chronic hepatitis C- related kidney disease and course and management of patients with chronic hepatitis C in special circumstances like hemodialysis and kidney transplantation.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…There is no consensus guideline concerning the management of chronic hepatitis C patients during chemotherapy, and immunosuppression. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso

“…Hepatitis C virus (HCV) infection is relatively common among patients with end-stage kidney disease (ESKD) on dialysis and kidney transplant recipients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Hepatitis C virus (HCV) is a Flavivirus with a positive-sense, single-stranded RNA genome of about 9,600 nucleotides. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Hepatitis-C-virus- (HCV-) related end-stage cirrhosis is the primary indication for liver transplantation in many countries. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Hepatitis C virus (HCV) is an RNA virus that is unable to integrate into the host genome. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Abstract Combination therapy with pegylated interferon alfa (PEG-IFN alfa) and the nucleoside analogue ribavirin is the current standard of care in patients infected with hepatitis C virus (HCV). Patients with HCV genotype 1 have a much less favorable response to therapy and are treated for 12 months, compared with patients infected with genotypes 2 and 3, in whom a 6-month course of therapy is sufficient. …”
Enlace del recurso
Enlace del recurso

“…The combination of pegylated interferon (PEG-IFN) and ribavirin (RBV), the current therapy for hepatitis C virus (HCV) infection, has saved the lives of many HCV-infected patients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Hepatitis C virus infection is associated with several extrahepatic manifestations. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The current treatments for chronic hepatitis C virus (HCV) genotype 1 infection are combinations of direct-acting antivirals, and faldaprevir is one of the new generation of HCV NS3/4A protease inhibitors. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Hepatitis C is a global epidemic. Worldwide, 185 million people are estimated to be infected, most of whom live in low- and middle-income countries. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…It is now a full decade since Paylor and Orgel (2004) called for social work to ‘wake up’ to hepatitis C (HCV). In that time, a small but significant body of social research has developed which has highlighted the far-reaching social consequences of living with HCV. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Hepatitis C is a global health issue and constitutes a major cause of chronic liver disease worldwide. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…CASE PRESENTATION: We report a case of a 65-year-old male who was known to have chronic hepatitis C presented with one-year history of shortness of breath and cyanosis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso